Alaunos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alaunos Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-04-01 | $-5.50 | $-4.50 | -22.2 % |
Q3 | 2023-11-14 | $-6.00 | $-4.50 | -33.3 % |
Q2 | 2023-08-14 | $-6.00 | $-6.00 | 0.00 % |
Q1 | 2023-05-10 | $-6.00 | $-6.00 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Alaunos Therapeutics (TCRT) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.70, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.